XU WEIHAO enters CASI PHARMACEUTICALS, INC (DE) with 4K shares across direct and indirect positions
This filing by XU WEIHAO (Chief Financial Officer) establishes the baseline for all future Form 4 insider transaction reports at CASI PHARMACEUTICALS, INC (DE).
Indirect
Filed: 12/18/2020ACC: 0001104659-20-137410
Officer· Chief Financial Officer
Since Dec 2020
4K
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
4K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned4K
Total
4K indirect4K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4K | Indirect |
| Total | 4K | 4K indirect |
Derivative Holdings0
No derivative holdings reported